Help protect what matters
most for people like Joe

Support for you and your patients
with NVAF through:

  • A treatment for high-risk patients that is in
    line with NHS and BSH guidance to help
    reduce exposure to COVID-191,6,7
  • A reassuring efficacy and safety profile11–13
  • A simple switch from VKA and straightforward
    dosing regimen, without the need for
    additional coagulation monitoring1

Which of your NVAF patients with diabetes can you help protect with Xarelto?